URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Janet Casey

Concepts (246)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Otitis Media
23
2002
122
7.440
Why?
Anti-Bacterial Agents
26
2003
436
7.190
Why?
Pharyngitis
15
2000
93
5.700
Why?
Tonsillitis
13
2000
59
4.770
Why?
Streptococcus pyogenes
13
2003
102
4.740
Why?
Streptococcal Infections
14
2000
171
3.770
Why?
Penicillins
12
2000
89
3.470
Why?
Cephalosporins
9
2000
67
3.440
Why?
Pneumococcal Infections
9
2007
92
2.630
Why?
Streptococcus pneumoniae
13
2005
113
2.320
Why?
Haemophilus Infections
9
2009
77
1.630
Why?
Pneumococcal Vaccines
6
2005
75
1.620
Why?
Acute Disease
15
2002
580
1.560
Why?
Haemophilus influenzae
12
2005
135
1.550
Why?
Nasopharynx
6
2010
46
1.530
Why?
Whooping Cough
4
2003
41
1.500
Why?
Clinical Trials as Topic
7
2002
675
1.460
Why?
Infant
28
1997
2249
1.460
Why?
Child, Preschool
29
1996
2612
1.430
Why?
Amoxicillin
6
2003
37
1.200
Why?
Child
25
1997
4086
1.180
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
3
2005
27
1.150
Why?
Randomized Controlled Trials as Topic
7
2003
409
1.080
Why?
Severity of Illness Index
6
2002
919
1.050
Why?
Otitis Media with Effusion
4
2003
36
1.040
Why?
Humans
56
1994
36400
0.990
Why?
Azithromycin
2
2003
19
0.980
Why?
Antibodies, Bacterial
7
2005
187
0.970
Why?
Drug Resistance, Multiple, Bacterial
4
2004
24
0.940
Why?
Vaccines, Conjugate
4
2005
44
0.910
Why?
Physician's Practice Patterns
2
2003
253
0.890
Why?
Treatment Outcome
13
1997
2623
0.840
Why?
Communicable Diseases, Emerging
2
2007
8
0.800
Why?
Bacterial Infections
3
2003
125
0.760
Why?
Moraxellaceae Infections
1
2010
3
0.740
Why?
Prospective Studies
12
2003
1677
0.720
Why?
Bacterial Outer Membrane Proteins
4
2009
62
0.720
Why?
Microbial Sensitivity Tests
7
2003
170
0.700
Why?
Diagnostic Errors
1
2008
89
0.630
Why?
Adolescent
13
1997
4752
0.630
Why?
Bacterial Proteins
5
2007
377
0.620
Why?
Treatment Failure
5
2004
130
0.610
Why?
Ambulatory Care
1
2008
152
0.610
Why?
Hemolysin Proteins
1
2007
15
0.600
Why?
Leukocyte Count
2
2003
159
0.600
Why?
Drug Prescriptions
2
2003
42
0.600
Why?
Bordetella pertussis
2
2003
24
0.600
Why?
Patient Selection
1
2008
209
0.580
Why?
Drug Hypersensitivity
1
2007
36
0.580
Why?
Respiratory Tract Infections
2
2003
151
0.570
Why?
Haemophilus Vaccines
3
2009
61
0.540
Why?
Pertussis Vaccine
1
2005
34
0.520
Why?
Adult
12
1997
11345
0.490
Why?
Pediatrics
1
2008
390
0.480
Why?
Polymerase Chain Reaction
4
1994
594
0.470
Why?
Drug Administration Schedule
7
2000
369
0.460
Why?
Anti-Infective Agents
2
2002
74
0.450
Why?
Antigens, Bacterial
3
2011
91
0.440
Why?
Recurrence
5
2003
697
0.440
Why?
Fever
1
2003
100
0.430
Why?
Moraxella (Branhamella) catarrhalis
4
2005
12
0.420
Why?
Cephalexin
3
2003
12
0.420
Why?
Serotyping
4
2005
68
0.410
Why?
Immunologic Memory
3
2006
124
0.370
Why?
United States
4
2006
2630
0.360
Why?
Male
23
1996
19713
0.360
Why?
Meningococcal Vaccines
4
2005
25
0.360
Why?
Multilocus Sequence Typing
4
2010
11
0.340
Why?
beta-Lactamases
3
2005
30
0.340
Why?
Immunoglobulin G
5
2009
482
0.340
Why?
Female
21
1997
19826
0.330
Why?
Tympanic Membrane
2
2008
20
0.330
Why?
Bacterial Typing Techniques
4
2005
24
0.280
Why?
Placebos
2
2003
182
0.270
Why?
Penicillin V
2
2003
27
0.270
Why?
Cefadroxil
2
2003
10
0.270
Why?
Middle Ear Ventilation
2
2004
12
0.260
Why?
New York
4
2004
1282
0.260
Why?
Evidence-Based Medicine
2
2007
199
0.260
Why?
Penicillin Resistance
2
2000
30
0.250
Why?
Retrospective Studies
4
2007
2260
0.250
Why?
Ear, Middle
2
2010
17
0.250
Why?
Carrier State
2
2010
32
0.240
Why?
Cohort Studies
3
2003
969
0.240
Why?
Serum
2
2010
13
0.240
Why?
Diagnosis, Differential
3
2003
878
0.220
Why?
Receptors, Cell Surface
1
1994
215
0.220
Why?
Follow-Up Studies
4
2003
1857
0.220
Why?
Coinfection
1
2012
5
0.210
Why?
Time Factors
3
2003
3201
0.210
Why?
Diphtheria Toxoid
3
2005
34
0.210
Why?
Antibiosis
1
2011
2
0.200
Why?
ROC Curve
1
2011
126
0.190
Why?
Sensitivity and Specificity
2
2010
905
0.190
Why?
Conserved Sequence
1
2011
103
0.190
Why?
Polysaccharides, Bacterial
3
2004
102
0.180
Why?
Bacteria
1
2010
81
0.180
Why?
Intercellular Adhesion Molecule-1
1
2010
127
0.170
Why?
Epidemiologic Research Design
1
2008
3
0.170
Why?
Otoscopy
1
2008
5
0.170
Why?
Process Assessment (Health Care)
1
2008
11
0.170
Why?
Predictive Value of Tests
1
2011
601
0.170
Why?
Milk, Human
1
2009
81
0.170
Why?
Bias (Epidemiology)
1
2008
44
0.170
Why?
Drug Utilization
1
2008
47
0.160
Why?
Meningococcal Infections
2
2005
12
0.160
Why?
Reproducibility of Results
2
2008
884
0.160
Why?
Paracentesis
1
2008
8
0.160
Why?
Exudates and Transudates
1
2008
16
0.160
Why?
CD4-Positive T-Lymphocytes
1
2011
296
0.160
Why?
Double-Blind Method
2
2005
998
0.160
Why?
Infant, Newborn
3
2000
1831
0.160
Why?
Molecular Epidemiology
1
2007
11
0.160
Why?
Mannosyltransferases
1
2007
1
0.150
Why?
Congenital Disorders of Glycosylation
1
2007
1
0.150
Why?
B-Lymphocytes
1
2012
453
0.150
Why?
Outcome and Process Assessment (Health Care)
1
2008
84
0.150
Why?
Siblings
1
2007
33
0.150
Why?
Cephaloridine
1
2007
2
0.150
Why?
Cefamandole
1
2007
3
0.150
Why?
Immunoglobulin E
1
2007
48
0.150
Why?
Cross Reactions
1
2007
107
0.150
Why?
Safety
1
2007
101
0.140
Why?
Age Factors
2
2006
1121
0.140
Why?
Immunization, Secondary
1
2006
71
0.140
Why?
Breast Feeding
1
2009
179
0.140
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2006
66
0.140
Why?
Europe
1
2006
79
0.140
Why?
Acoustic Impedance Tests
1
2005
12
0.140
Why?
Phylogeny
3
2009
117
0.140
Why?
Macrolides
1
2005
18
0.140
Why?
Vaccines, Acellular
1
2005
4
0.130
Why?
Cost of Illness
1
2005
74
0.130
Why?
Outcome Assessment (Health Care)
2
2003
293
0.130
Why?
Neisseria meningitidis
1
2005
21
0.130
Why?
Odds Ratio
1
2006
304
0.130
Why?
Autoimmune Diseases of the Nervous System
1
2004
6
0.130
Why?
Combined Modality Therapy
2
1997
486
0.130
Why?
Gram-Positive Bacteria
1
2004
11
0.130
Why?
Behavioral Symptoms
1
2004
15
0.130
Why?
Gram-Negative Bacteria
1
2004
21
0.130
Why?
Health Care Costs
1
2005
112
0.120
Why?
Publication Bias
1
2004
8
0.120
Why?
Sex Distribution
1
2004
154
0.120
Why?
Drug Therapy, Combination
1
2005
390
0.120
Why?
Age Distribution
1
2004
216
0.120
Why?
Young Adult
1
2008
1074
0.120
Why?
RNA, Bacterial
1
2003
81
0.110
Why?
Antibodies, Monoclonal
1
2007
732
0.110
Why?
Practice Guidelines as Topic
1
2005
304
0.110
Why?
Sequence Homology, Nucleic Acid
2
1994
143
0.100
Why?
Incidence
1
2004
679
0.100
Why?
Risk Factors
2
2004
2318
0.100
Why?
Chronic Disease
1
2003
530
0.100
Why?
Cognition Disorders
1
2004
278
0.100
Why?
DNA Primers
2
1994
414
0.090
Why?
Dose-Response Relationship, Drug
1
2003
1138
0.090
Why?
DNA, Bacterial
2
2009
174
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
466
0.080
Why?
Base Sequence
2
1994
1704
0.080
Why?
Molecular Sequence Data
2
1994
2028
0.070
Why?
Extracorporeal Membrane Oxygenation
1
1996
22
0.070
Why?
Bone Marrow Transplantation
1
1997
186
0.070
Why?
Anemia, Sickle Cell
1
1996
48
0.070
Why?
Respiratory Insufficiency
1
1996
57
0.070
Why?
Hematopoietic Stem Cell Transplantation
1
1997
117
0.070
Why?
Respiratory Distress Syndrome, Adult
1
1996
78
0.060
Why?
Erabutoxins
1
1994
1
0.060
Why?
Neoplasm Recurrence, Local
1
1997
286
0.060
Why?
Snakes
1
1994
3
0.060
Why?
Receptors, Urokinase Plasminogen Activator
1
1994
9
0.060
Why?
Genomic Library
1
1994
15
0.060
Why?
Glycosylphosphatidylinositols
1
1994
8
0.060
Why?
Multigene Family
1
1994
74
0.060
Why?
Urokinase-Type Plasminogen Activator
1
1994
64
0.060
Why?
Exons
1
1994
163
0.060
Why?
Brain Neoplasms
1
1997
282
0.060
Why?
Sequence Homology, Amino Acid
1
1994
288
0.060
Why?
HeLa Cells
1
1994
297
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1997
430
0.060
Why?
Questionnaires
2
2004
998
0.050
Why?
Disease Susceptibility
1
2011
80
0.050
Why?
Chinchilla
1
2011
8
0.050
Why?
Consensus
1
2011
14
0.050
Why?
Streptolysins
1
2011
12
0.050
Why?
Drug Resistance, Bacterial
1
2011
47
0.050
Why?
Interdisciplinary Communication
1
2011
41
0.050
Why?
Immunoglobulin D
1
2010
12
0.050
Why?
Oropharynx
1
2010
11
0.050
Why?
Amino Acid Sequence
1
1994
1231
0.050
Why?
Epitopes
1
2011
202
0.050
Why?
Mutation, Missense
1
2011
87
0.050
Why?
Sequence Analysis, DNA
1
2011
164
0.050
Why?
Lipoproteins
1
2010
99
0.040
Why?
Infant Formula
1
2009
12
0.040
Why?
Antibody Formation
1
2010
176
0.040
Why?
Observer Variation
1
2009
143
0.040
Why?
Medical Records
1
2009
125
0.040
Why?
Patient Participation
1
2009
74
0.040
Why?
Genes, Bacterial
1
2009
161
0.040
Why?
Delayed-Action Preparations
1
2008
43
0.040
Why?
Single-Blind Method
1
2008
118
0.040
Why?
Pain Measurement
1
2009
243
0.040
Why?
Muscle Hypotonia
1
2007
7
0.040
Why?
Genetic Complementation Test
1
2007
56
0.040
Why?
Glycosylation
1
2007
64
0.040
Why?
Blindness
1
2007
35
0.040
Why?
Sex Factors
1
2009
584
0.040
Why?
Heterozygote
1
2007
122
0.040
Why?
Antibody Affinity
1
2006
13
0.040
Why?
Chi-Square Distribution
1
2008
333
0.040
Why?
Blood Bactericidal Activity
1
2006
17
0.040
Why?
Diphtheria
1
2006
13
0.040
Why?
Tetanus
1
2006
17
0.040
Why?
Cross-Sectional Studies
1
2009
621
0.040
Why?
DNA Mutational Analysis
1
2007
189
0.040
Why?
Immunoglobulin A
1
2006
90
0.040
Why?
DNA, Complementary
1
2007
261
0.040
Why?
Tetanus Toxoid
1
2006
40
0.040
Why?
Carrier Proteins
1
2010
434
0.030
Why?
Seizures
1
2007
143
0.030
Why?
Animals
2
1994
16270
0.030
Why?
Risk Assessment
1
2009
878
0.030
Why?
Central Nervous System Viral Diseases
1
2004
4
0.030
Why?
Phenotype
1
2007
762
0.030
Why?
Child Welfare
1
2004
72
0.030
Why?
Mice
1
1994
6103
0.030
Why?
Psychomotor Performance
1
2004
165
0.030
Why?
Administration, Oral
1
2003
309
0.030
Why?
Neuropsychological Tests
1
2004
375
0.030
Why?
Multivariate Analysis
1
2004
531
0.030
Why?
Mutation
1
2007
1229
0.020
Why?
Streptococcus
1
2000
79
0.020
Why?
Pinealoma
1
1997
4
0.020
Why?
Busulfan
1
1997
9
0.020
Why?
Melphalan
1
1997
27
0.020
Why?
Ependymoma
1
1997
10
0.020
Why?
Medulloblastoma
1
1997
19
0.020
Why?
Fibrosarcoma
1
1997
27
0.020
Why?
Transplantation, Autologous
1
1997
144
0.020
Why?
Cyclophosphamide
1
1997
173
0.020
Why?
Glioblastoma
1
1997
63
0.020
Why?
Radiography, Thoracic
1
1996
62
0.020
Why?
Syndrome
1
1996
210
0.020
Why?
African Continental Ancestry Group
1
1996
121
0.020
Why?
Oxygen Consumption
1
1996
206
0.020
Why?

Visualizations


Casey's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department